These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1483066)

  • 1. Evaluation of the biological significance of leukocyte infiltration of the thyroid in Graves' disease.
    Levis S; Ghandur-Mnaymneh L; McKenzie JM; Zakarija M
    Int Arch Allergy Immunol; 1992; 99(1):37-43. PubMed ID: 1483066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease.
    Grubeck-Loebenstein B; Londei M; Greenall C; Pirich K; Kassal H; Waldhäusl W; Feldmann M
    J Clin Invest; 1988 May; 81(5):1608-14. PubMed ID: 3130398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intercellular adhesion molecule-1 (ICAM-1) in Graves' disease: contrast between in vivo and in vitro results.
    Ciampolillo A; Napolitano G; Mirakian R; Miyasaki A; Giorgino R; Bottazzo GF
    Clin Exp Immunol; 1993 Dec; 94(3):478-85. PubMed ID: 7902787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
    Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies.
    Lucas-Martin A; Foz-Sala M; Todd I; Bottazzo GF; Pujol-Borrell R
    J Clin Endocrinol Metab; 1988 Feb; 66(2):367-75. PubMed ID: 3276724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease.
    Jaspan JB; Sullivan K; Garry RF; Lopez M; Wolfe M; Clejan S; Yan C; Tenenbaum S; Sander DM; Ahmed B; Bryer-Ash M
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2271-9. PubMed ID: 8964863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect?
    Sospedra M; Obiols G; Babi LF; Tolosa E; Vargas F; Roura-Mir C; Lucas-Martin A; Ercilla G; Pujol-Borrell R
    J Immunol; 1995 Apr; 154(8):4213-22. PubMed ID: 7706756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells.
    Faure GC; Bensoussan-Lejzerowicz D; Bene MC; Aubert V; Leclere J
    Clin Immunol Immunopathol; 1997 Aug; 84(2):212-5. PubMed ID: 9245555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of lymphocytes and thyrocytes in Graves' disease and nonautoimmune thyroid diseases in immunohistochemical and ultrastructural investigations.
    Ben-Skowronek I; Sierocinska-Sawa J; Szewczyk L; Korobowicz E
    Horm Res; 2009; 71(6):350-8. PubMed ID: 19506393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological features of nonimmunogenic hyperthyroidism.
    Grubeck-Loebenstein B; Derfler K; Kassal H; Knapp W; Krisch K; Liszka K; Smyth PP; Waldhäusl W
    J Clin Endocrinol Metab; 1985 Jan; 60(1):150-5. PubMed ID: 2856880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of adhesion molecules in thyroid glands from patients with Graves' disease.
    Nakashima M; Eguchi K; Ida H; Yamashita I; Sakai M; Origuchi T; Kawabe Y; Ishikawa N; Ito K; Nagataki S
    Thyroid; 1994; 4(1):19-25. PubMed ID: 7519914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity of thyroid disease. With emphasis on Graves' disease.
    van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G
    Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065
    [No Abstract]   [Full Text] [Related]  

  • 13. The pathogenetic connection between Graves' disease and chronic lymphocytic thyroiditis. (The role and incidence of thyroid stimulating antibodies).
    Leövey A; Bakó G; Sztojka I; Bordán L; Szabó T; Kálmán K; Balázs C
    Acta Med Acad Sci Hung; 1982; 39(1-2):1-6. PubMed ID: 6129766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
    Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM
    J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Graves' intrathyroidal lymphocytes. Effect of Graves' disease intrathyroidal lymphocytes (ITL) on xenotransplants of human thyroid tissue in athymic nude mice.
    Schumm-Draeger PM; Jungheim K; Caspar G; Hermann G; Fortmeyer HP; Wenisch HJ; Usadel KH
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():60-3. PubMed ID: 8981004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease.
    Hopf U; Fiek T; Grün R; Zuschneid W
    J Clin Lab Immunol; 1982 Oct; 9(1):49-53. PubMed ID: 6757440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell subsets and thyroid-stimulating antibodies in patients with Graves' disease in clinical remission.
    Bagnasco M; Macchia E; Ciprandi G; Caria M; Fenzi GF
    J Endocrinol Invest; 1986 Jun; 9(3):217-21. PubMed ID: 2876022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
    Arnold K; Metcalfe R; Weetman AP
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methimazole has no dose-related effect on the intensity of the intrathyroidal autoimmune process in relapsing Graves' disease.
    Paschke R; Vogg M; Kristoferitsch R; Aktuna D; Wawschinek O; Eber O; Usadel KH
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2470-4. PubMed ID: 7629244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
    Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
    Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.